Physician profile
Mindy Nestampower
NPI 1851476626
$885.41
in general payments reported to CMS, 2019-2025
11 companies · $634 in 2025
The $634 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.41 · 2021: $31.96 · 2022: $22.80 · 2023: $17.23 · 2024: $161 · 2025: $634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $500 · Food and Beverage: $312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $500.00 |
| Food and Beverage | $312.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mindray Ds USA, INC. | $500.00 | 2025 | |
| Heron Therapeutics, INC. | $115.19 | 2025 | Aponvie |
| Merck Sharp & Dohme LLC | $79.14 | 2024 | Dificid, Zinplava |
| Takeda Pharmaceuticals U.S.A., INC. | $37.59 | 2024 | Entyvio |
| Bioventus LLC | $31.96 | 2021 | |
| Braintree Laboratories, INC. | $25.78 | 2024 | Sutab, Suflave |
| Cook Medical LLC | $22.80 | 2022 | |
| Biocon Biologics INC | $19.15 | 2025 | Yesintek |
| Omeros Corporation | $18.41 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.16 | 2024 | |
| Abbvie INC. | $17.23 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mindy Nestampower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.